Relative risks of adverse effects across different opioid agonist treatments-A systematic review and meta-analysis.
Authors
Meyer M, Strazdins E, Guessoum A, Westenberg JN, Appenzeller-Herzog C, Cattaneo MEGV, Krausz RM, Dürsteler KM, Lang UE, Hemkens LG, Vogel M
Abstract
Opioid agonist treatment (OAT) is established for opioid use disorder, but limited data on adverse effects exist. We aimed to review relative risks of adverse effects across opioid agonists.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
